| Literature DB >> 28878860 |
Soraya Mendoza-Olazarán1, José F Garcia-Mazcorro2, Rayo Morfín-Otero3, Licet Villarreal-Treviño4, Adrián Camacho-Ortiz5, Eduardo Rodríguez-Noriega3, Paola Bocanegra-Ibarias1, Héctor J Maldonado-Garza1, Scot E Dowd6, Elvira Garza-González1.
Abstract
Herein, we report the draft-genome sequences and annotation of two opportunistic pathogenic strains of Staphylococcus cohnii isolated from humans. One strain (SC-57) was isolated from blood from a male patient in May 2006 and the other (SC-532) from a catheter from a male patient in June 2006. Similar to other genomes of Staphylococcus species, most genes (42%) of both strains are involved in metabolism of amino acids and derivatives, carbohydrates and proteins. Eighty (4%) genes are involved in virulence, disease, and defense and both species show phenotypic low biofilm production and evidence of increased antibiotic resistance associated to biofilm production. From both isolates, a new Staphylococcal Cassette Chromosome mec was detected: mec class A, ccr type 1. This is the first report of whole genome sequences of opportunistic S. cohnii isolated from human patients.Entities:
Keywords: Biofilm; Clinical strains; Coagulase-negative staphylococci; SCCmec; Short genome report; Staphylococcus cohnii
Year: 2017 PMID: 28878860 PMCID: PMC5580220 DOI: 10.1186/s40793-017-0263-1
Source DB: PubMed Journal: Stand Genomic Sci ISSN: 1944-3277
Fig. 1Gram stain of isolates SC-57 (a) and SC -532 (b) using light microscopy at magnification 100×
Classification and general features of Staphylococcus cohnii strains SC-57 and SC-532 [10]
| MIGS ID | Property | Term | Evidence codea |
|---|---|---|---|
| Classification | Domain | TAS [ | |
| Phylum | TAS [ | ||
| Class | TAS [ | ||
| Order | TAS [ | ||
| Family | TAS [ | ||
| Genus | TAS [ | ||
| Species | TAS [ | ||
| Strains: SC-57 and SC-532 | IDA | ||
| Gram stain | Positive | IDA | |
| Cell shape | coccus | IDA | |
| Motility | Nonmotile | IDA | |
| Sporulation | Nonsporulating | IDA | |
| Temperature range | 15–45 °C | IDA | |
| Optimum temperature | 37 °C | IDA | |
| pH range; Optimum | 6.5–7.5, 7 | IDA | |
| Carbon source | D-mannitol, fructose, trehalose, glucose, mannose, lactose, | IDA | |
| MIGS-6 | Habitat | Skin | IDA |
| MIGS-6.3 | Salinity | Tolerates 10% NaCl ( | IDA |
| MIGS-22 | Oxygen requirement | Facultative anaerobic | IDA |
| MIGS-15 | Biotic relationship | Free living | IDA |
| MIGS-14 | Pathogenicity | Opportunistic pathogenic | IDA |
| MIGS-4 | Geographic location | Monterrey, Mexico | IDA |
| MIGS-5 | Sample collection | May 23, 2006 (SC-57), June 8, 2006 (SC-532) | IDA |
| MIGS-4.1 | Latitude | 25.6714. | IDA |
| MIGS-4.2 | Longitude | −100.309 | IDA |
| MIGS-4.4 | Altitude | 534 m | IDA |
a Evidence codes - IDA: Inferred from Direct Assay; TAS: Traceable Author Statement (i.e., a direct report exists in the literature); NAS: Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [19]
Fig. 2Phylogenetic tree based on 16S rRNA gene sequences of the genus Staphylococcus. The names and corresponding accession numbers are shown, including the S. cohnii (SC-57) sequence from this study, which was 100% similar to SC-532. Sequences were aligned using Clustal W2 and MUSCLE [13] and uploaded in DAMBE [15] to build a phylogenetic tree using a Maximum Likelihood method with the GTR substitution model, rate heterogeneity among sites modeled by a gamma distribution, and 1000 bootstrap samples. The number at the nodes represents bootstrap support. Generated with the ‘Quick add’ option on, and the number of branches allowed to cross during tree searching set to 1 for local optimization. Bacillus subtilis subsp. subtilis (AB598736) was chosen as the out-group to root the tree
Project information
| MIGS ID | Property | SC-57 | SC-532 |
|---|---|---|---|
| MIGS-31 | Finishing quality | High-quality draft | High-quality draft |
| MIGS-28 | Libraries used | 2 × 250 bp | 2 × 250 bp |
| MIGS-29 | Sequencing platforms | MiSeq Illumina | MiSeq Illumina |
| MIGS-31.2 | Fold coverage | >40× (based on 500 bp library) | >40× (based on 500 bp library) |
| MIGS-30 | Assemblers | NGEN-Assembler | NGEN-Assembler |
| MIGS-32 | Gene calling method | NCBI PGAP pipeline | NCBI PGAP pipeline |
| Locus Tag | XA22 | XA21 | |
| GenBank ID | NZ_LATU00000000 | NZ_LATV00000000 | |
| GenBank date of Release | April 15, 2015 | April 15, 2015 | |
| GOLD ID | Gp0119449 | Gp0119450 | |
| BIOPROJECT | PRJNA279286 | PRJNA279286 | |
| MIGS-13 | Source Material Identifier | SAMN03449103 | SAMN03449104 |
| Project relevance | Clinical | Clinical |
Genome statistics
| SC-57 | SC-532 | |||
|---|---|---|---|---|
| Attribute | Value | % of Total | Value | % of Total |
| Genome size (bp) | 2,853,167 | 100.00 | 2,826,849 | 100.00 |
| DNA coding (bp) | 2,852,026 | 99.96 | 2,404,235 | 85.05 |
| DNA G + C (bp) | 951,817 | 33.36 | 943,037 | 33.36 |
| DNA scaffolds | 20 | 100.00 | 16 | 100.00 |
| Total genes | 2779 | 100.00 | 2755 | 100.00 |
| Protein coding genes | 2635 | 100.00 | 2620 | 100.00 |
| RNA genes | 80 | 3.04 | 78 | 2.98 |
| Pseudo genes | 64 | 2.32 | 57 | 2.15 |
| Genes in internal clusters | 232 | 8.75 | 211 | 7.99 |
| Genes with function prediction | 2256 | 85.13 | 2155 | 81.63 |
| Genes assigned to COGs | 1999 | 75.43 | 1982 | 75.08 |
| Genes with Pfam domains | 2284 | 86.19 | 2263 | 85.72 |
| Genes with signal peptides | 61 | 2.30 | 61 | 2.31 |
| Genes with transmembrane helices | 668 | 25.21 | 673 | 25.49 |
| CRISPR repeats | 1 | 1 | ||
Number of genes associated with general COG functional categories
| SC-57 | SC-532 | ||||
|---|---|---|---|---|---|
| Code | Value | % age | Value | % age | Description |
| J | 198 | 8.92 | 199 | 9.05 | Translation, ribosomal structure and biogenesis |
| A | 82 | 3.69 | 81 | 3.69 | RNA processing and modification |
| K | 153 | 6.89 | 151 | 6.87 | Transcription |
| L | 102 | 4.59 | 100 | 4.55 | Replication, recombination and repair |
| B | 1 | 0.05 | 1 | 0.05 | Chromatin structure and dynamics |
| D | 27 | 1.22 | 27 | 1.23 | Cell cycle control, Cell division, chromosome partitioning |
| V | 48 | 2.16 | 43 | 1.96 | Defense mechanisms |
| T | 67 | 3.02 | 67 | 3.05 | Signal transduction mechanisms |
| M | 101 | 4.55 | 101 | 4.6 | Cell wall/membrane biogenesis |
| N | 4 | 0.18 | 4 | 0.18 | Cell motility |
| U | 14 | 0.63 | 14 | 0.64 | Intracellular trafficking and secretion |
| O | 82 | 3.69 | 81 | 3.69 | Posttranslational modification, protein turnover, chaperones |
| C | 117 | 5.27 | 117 | 5.32 | Energy production and conversion |
| G | 170 | 7.66 | 168 | 7.64 | Carbohydrate transport and metabolism |
| E | 206 | 9.28 | 205 | 9.33 | Amino acid transport and metabolism |
| F | 88 | 3.96 | 86 | 3.91 | Nucleotide transport and metabolism |
| H | 142 | 6.4 | 141 | 6.41 | Coenzyme transport and metabolism |
| I | 99 | 4.46 | 98 | 4.46 | Lipid transport and metabolism |
| P | 144 | 6.49 | 144 | 6.55 | Inorganic ion transport and metabolism |
| Q | 47 | 2.12 | 47 | 2.14 | Secondary metabolites biosynthesis, transport and catabolism |
| R | 200 | 9.01 | 197 | 8.96 | General function prediction only |
| S | 167 | 7.52 | 168 | 7.64 | Function unknown |
| - | 651 | 24.57 | 658 | 24.92 | Not in COGs |
The total is based on the total number of protein coding genes in the genome
Antibiotic resistance of biofilm and planktonic cells of SC-57 and SC-532
| SC-57 | SC-532 | ||||
|---|---|---|---|---|---|
| Antibiotic | Cells | MIC/MBECa (μg/mL) | Interpretationb | MIC/MBECa (μg/mL) | Interpretationb |
| Oxacillin | Planktonic | 8 | R | 2 | R |
| Biofilm | 16 | R | 4 | R | |
| Amikacin | Planktonic |
| R |
| R |
| Biofilm |
| R |
| R | |
| Vancomycin | Planktonic | 0.25 | S |
| S |
| Biofilm | 0.5 | S |
| S | |
| Erythromycin | Planktonic |
| S |
| S |
| Biofilm |
| R |
| R | |
| Trimethoprim | Planktonic | 64 | R | 16 | R |
| Biofilm | 128 | R | 32 | R | |
| Ciprofloxacin | Planktonic |
| R | 0.5 | S |
| Biofilm |
| R | 0.5 | S | |
| Chloramphenicol | Planktonic | 32 | R | 4 | S |
| Biofilm | 32 | R | 8 | S | |
| Linezolid | Planktonic | 1 | S |
| S |
| Biofilm | 2 | S |
| R | |
aMIC: minimum inhibitory concentrations (planktonic cells), MBEC Minimum biofilm eradication concentration (biofilm cells). Values in italic indicate a significant difference (increase ≥2 fold) in MICs and MBECs between planktonic and biofilm cells. b R and S: resistant and susceptible, respectively